Cango (NYSE:CANG) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 73.81 percent increase over losses of $(0.42) per share from the same period last year.
Guggenheim Upgrades Macrogenics to Buy, Announces $12 Price Target
Guggenheim analyst Charles Zhu upgrades Macrogenics (NASDAQ:MGNX) from Neutral to Buy and announces $12 price target.
